Team:Freiburg Bioware

From 2010.igem.org

(Difference between revisions)
Line 140: Line 140:
margin: 20px 20px 20px 50px;
margin: 20px 20px 20px 50px;
float: right;
float: right;
 +
}
 +
 +
img.spon5 {
 +
margin: 10px 20px 10px 20px;
}
}
Line 155: Line 159:
font-weight: bold;
font-weight: bold;
color: #444444;
color: #444444;
 +
margin: 10px 0px 20px 15px;
}
}
</style>
</style>
Line 222: Line 227:
<!--Sponsors-->
<!--Sponsors-->
-
<p id="sponsors">our sponsors:</p>
+
<div class="box_right">
 +
<p id="sponsors">Sponsors:</p>
 +
</div>
 +
<br />
<center>
<center>
<a href="http://www.uni-freiburg.de/start-en.html?set_language=en" target="_blank"><img src="http://www.molbiotech.uni-freiburg.de/iGEM/images/uni_logo.jpg" class="spon5" alt="Uni Freiburg" width="auto" height="170"/></a>
<a href="http://www.uni-freiburg.de/start-en.html?set_language=en" target="_blank"><img src="http://www.molbiotech.uni-freiburg.de/iGEM/images/uni_logo.jpg" class="spon5" alt="Uni Freiburg" width="auto" height="170"/></a>

Revision as of 19:12, 6 September 2010

virus

In the last years the number of people affected by cancer increased significantly. About 25% cases of death are caused by malign tumors. Even though the industry is putting great efforts into developing effective strategies against cancer, innovative methods to fight tumors are needed. This year’s aim of Freiburg Bioware team 2010 is to create a universal virus construction kit which can be designed by submitted BioBricks. Our goal is to knockout the natural tropism of adeno-associated virus particles and to specifically target tumor cells by genetic engineering of the viral surface. The recombinant viruses will contain different genes coding for enzymes which convert harmless drugs into toxic molecules in targeted cell and kill the tumor cells. This approach will be a great advance in improving the growing field of personalized medicine.

Sponsors:


Uni Freiburg Bioss kuk.lab
Roche DAAD Starlab Qiagen
agilent Hiss Fermentas Zeiss Geneart Eppendorf Gilson ATG Biozym